David Harrison

September 9, 2024

Peptide discovery could advance treatment of high blood pressure

VUMC researchers found that peptides modified by highly reactive compounds called isolevuglandins activated T cells and promoted hypertension in mice. Their first-ever isolation of such peptides is a step toward potentially intervening in this pathologic process.

By Bill Snyder
November 17, 2022

Several from VUMC among most highly cited researchers

Nine current faculty members of the Vanderbilt University School of Medicine have made this year’s list of scientists whose papers have been cited most frequently by other researchers.

By Bill Snyder
August 30, 2022

A new mechanism for lupus

Vanderbilt researchers describe a new mechanism for the most common form of lupus and suggest a new treatment approach to this autoimmune disease.

By Leigh MacMillan
June 2, 2022

VUMC renewed as a Comprehensive Hypertension Center

The Vanderbilt Comprehensive Hypertension Center has been awarded renewal of the American Heart Association’s Comprehensive Hypertension Center Certification,

By Matt Batcheldor
November 15, 2018

Harrison awarded AHA Basic Research Prize for 2018

David G. Harrison, MD, the Betty and Jack Bailey Professor of Cardiology and director of the Division of Clinical Pharmacology at Vanderbilt University School of Medicine, has been awarded the American Heart Association’s Basic Research Prize for 2018.

By Bill Snyder
September 27, 2018

Stretch, inflammation and hypertension

New research sheds light on how changes in blood vessel forces enhance immune cell activation and promote hypertension.

By VUMC News and Communications
February 12, 2015

VU study explores inflammation, hypertension link

The evidence is increasing: the immune system and inflammation are key contributors to high blood pressure.
By Bill Snyder
October 24, 2014

Immune cells’ role in hypertension

Vanderbilt researchers have discovered that certain immune cells contribute to the development of hypertension, suggesting novel targets for treating the disease.
By Leigh MacMillan
July 10, 2014

AHA grant creates coalition to prevent heart disease, stroke

Vanderbilt University Medical Center is one of four institutions that are part of a new research network aimed at preventing heart disease and stroke, the two leading causes of death in the world.
By Kathy Whitney
June 13, 2013

Clinical Pharmacology celebrates 50th anniversary

Since it was founded in 1963, the Vanderbilt Division of Clinical Pharmacology has pioneered “translational science” and continues to transform medical practice worldwide, speakers at the division’s 50th anniversary scientific symposium said last week.
By Bill Snyder
November 29, 2012

Record number elected AAAS fellows

Seventeen members of Vanderbilt University’s faculty have been elected fellows of the American Association for the Advancement of Science (AAAS) this year.
By Bill Snyder
August 2, 2012

VU hosts international vascular biology research meeting

More than 100 students, faculty and scientists from around the world attended a four-day program on vascular biology research last week at Vanderbilt University.
By Bill Snyder